ADAR1 Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

ADAR1 Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Sell	201,008 -30,000	-13%	-$38.5K	0.01%	239
2026 Q1	$286K	Buy	231,008 +130,000	+129%	+$165K	0.02%	241
2025 Q4	$126K	Hold	101,008	–	–	0.01%	244
2025 Q3	$141K	Hold	101,008	–	–	0.01%	194
2025 Q2	$107K	Hold	101,008	–	–	0.02%	173
2025 Q1	$110K	Hold	101,008	–	–	0.02%	162
2024 Q4	$153K	Hold	101,008	–	–	0.03%	168
2024 Q3	$151K	Buy	101,008 +51,008	+102%	+$78.8K	0.02%	176
2024 Q2	$81K	Buy	50,000 +40,000	+400%	+$72.1K	0.02%	175
2024 Q1	$17K	Buy	+10,000	New	+$18.7K	﹤0.01%	221

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

ADAR1 Capital Management's PMVP Position: Q2 2026 in Review

ADAR1 Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 13% in Q2 2026, selling an estimated $38.5K and leaving 201,008 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #239.

ADAR1 Capital Management first reported a position in PMVP in Q1 2024 and has held it in 10 quarters since. The position peaked at $286K in Q1 2026. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

ADAR1 Capital Management held 201,008 shares of PMV Pharmaceuticals worth $269K as of Q2 2026.
ADAR1 Capital Management sold 30,000 PMV Pharmaceuticals shares in Q2 2026, an estimated $38.5K.
PMV Pharmaceuticals made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #239 holding.
ADAR1 Capital Management first reported a position in PMV Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
ADAR1 Capital Management's PMV Pharmaceuticals position peaked at $286K in Q1 2026.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.